A phase <scp>II</scp> feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease ( <scp>YLOG0114</scp> )-Reference-Cited by-同舟云学术

A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease ( YLOG0114 )

Published:2022-03-23 Issue:9 Volume:13 Page:1267-1275
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Sakashita Hiroyuki¹^ORCID,Uchibori Ken¹^ORCID,Jin Yasuto²,Tsutsui Toshiharu³^ORCID,Honda Takayuki¹,Sakakibara Rie¹,Mitsumura Takahiro¹,Nukui Yoshihisa¹,Shirai Tsuyoshi¹,Masuo Masahiro¹,Suhara Kozo¹,Furusawa Haruhiko¹,Yamashita Takaaki⁴,Ohba Takehiko⁵,Saito Kazuhito⁶,Takagiwa Jun⁷,Miyashita Yoshihiro³,Inase Naohiko¹,Miyazaki Yasunari¹^ORCID

Affiliation:

1. Department of Respiratory Medicine Tokyo Medical and Dental University Tokyo Japan

2. Department of Respiratory Medicine Hiratsuka Kyosai Hospital Kanagawa Japan

3. Department of Respiratory Medicine Yamanashi Prefectural Central Hospital Yamanashi Japan

4. Department of Respiratory Medicine JA Toride General Medical Center Ibaraki Japan

5. Department of Pulmonology Ome Municipal General Hospital Tokyo Japan

6. Department of Respiratory Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan

7. Department of Pulmonology Tokyo Kyosai Hospital Tokyo Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14376

Reference25 articles.

1. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia

2. Real world data of combined lung cancer and interstitial lung disease

3. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias

4. Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan

5. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy;Scientific Reports;2024-05-03

2. Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection;Expert Review of Respiratory Medicine;2022-10-03

3. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy;Thoracic Cancer;2022-07-15